Community Research and Development Information Service - CORDIS

Therapeutic immunotherapy targeting NG2 and CD22 antigens for MLL-rearranged and MLL-germline B-cell Acute Lymphoblastic Leukemia

From 2019-01-01 to 2020-06-30, Grant Agreement signed

Project details

Total cost:

EUR 150 000

EU contribution:

EUR 150 000

Coordinated in:

Spain

Call for proposal:

ERC-2018-PoCSee other projects for this call

Funding scheme:

ERC-POC - Proof of Concept Grant

Objective

Host Institution

Fundació Institut de Recerca Contra la Leucemia Josep Carreras
Spain

EU contribution: EUR 150 000


CARRER MUNTANER 383 3/2
08021 BARCELONA
Spain
See on map
Activity type: Research Organisations

Contact the organisation

Beneficiaries

Fundació Institut de Recerca Contra la Leucemia Josep Carreras
Spain

EU contribution: EUR 150 000


CARRER MUNTANER 383 3/2
08021 BARCELONA
Spain
See on map
Activity type: Research Organisations

Contact the organisation

To know more

Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top